Celgene Chief Executive Officer Mark Alles discusses how the United States must rethink the way cancer patients pay for care at this week’s American Society of Clinical Oncology (ASCO) conference. Industry leaders must be engaged with political leaders to ensure that the most important medicines for the sickest patients are affordable and accessible, given that insurers often require high deductibles and high co-insurance for such treatments. To watch the full video click here.
Last Updated on May 13, 2020 by Aimed Alliance
